Brief: Zentiva Announces Sale From Advent To GTCR
11/09/2025 13:54
Sept 11 (Reuters) - Zentiva as 1SKF401E.BV: ZENTIVA, A LEADING EUROPEAN GENERICS PHARMACEUTICAL COMPANY, ANNOUNCES SALE FROM ADVENT TO GTCR ZENTIVA: DEAL CLOSING IS EXPECTED TO TAKE PLACE IN EARLY 2026 Source text: [ID:] Further company coverage: 1SKF401E.BV ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentiva as
See all newsBrief: Zentiva Publishes 2025 Sustainability Report Reinforcing Commitment To People, Partners And The Planet.
Brief: Zentiva As - Responds To EU Court Decision On Uwwtd
Media: Wall Street, private debt prep 3.6 billion euros on GTCR Zentiva deal- Bloomberg News
Private equity firm Advent to sell generic drugmaker Zentiva to GTCR (updated)
Deals of the Day-Mergers and acquisitions